How do I find clinical trials for stage 4 pancreatic cancer near Boston
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Finding Clinical Trials for Stage 4 Pancreatic Cancer Near Boston
I'm glad you're exploring clinical trial options—this is an important part of your care plan, especially for advanced pancreatic cancer where new treatment approaches can make a real difference.
How to Search for Clinical Trials
Primary Resource: ClinicalTrials.gov
- Go to www.clinicaltrials.gov
- Search terms to use: "pancreatic cancer" + "stage 4" or "metastatic"
- Filter by location: Massachusetts or Boston area
- Filter by recruitment status: "Recruiting" or "Not yet recruiting"
- You can also filter by specific treatments you're interested in (like KRAS inhibitors, immunotherapy, or vaccine trials)
Specialized Pancreatic Cancer Resources:
- PanCAN (Pancreatic Cancer Action Network): Visit their website for their clinical trial finder and "Know Your Tumor" program, which can help match you to trials based on your specific tumor mutations
- National Cancer Institute (NCI): Their Cancer Information Service can help locate trials (1-800-4-CANCER)
- Dana-Farber Cancer Institute and Massachusetts General Hospital (both in Boston) often have active pancreatic cancer trials
Why Genetic Testing Matters for Trial Eligibility
According to Dr. [removed] Strickler's guidance on precision cancer medicine, every pancreatic cancer patient should ask their doctor: "Have you done molecular profiling on my cancer?" This is now part of national guidelines.
Here's why this matters for trials:
- KRAS mutations are found in about 87% of pancreatic cancers and are increasingly targetable with new drugs
- Other mutations (BRCA, PALB2, mismatch repair defects) may qualify you for specific trials
- Tumor profiling results help match you to trials designed for your specific mutation profile
Action step: Request a copy of your molecular profiling report and bring it with you when exploring trials—this report often lives outside your main medical chart.
Questions to Ask Your Oncology Team
- "What is my tumor's molecular profile, and are there any mutations that would make me eligible for targeted therapy trials?"
- "Are there any early-stage vaccine trials or immunotherapy trials I might qualify for?" (Early data suggests cancer vaccines may be beneficial, though these are still in development)
- "Which Boston-area institutions have active pancreatic cancer trials that match my specific situation?"
- "Can you help me understand the pros and cons of any trials you recommend?"
- "If I participate in a trial, how will it affect my standard treatment plan?"
Important Context About Pancreatic Cancer Trials
According to the CancerPatientLab webinar on pancreatic cancer, the field is experiencing important breakthroughs:
- New KRAS-targeted therapies show promise with minimal side effects
- Cancer vaccine trials are in early stages but showing encouraging signals
- Trials work best when started with minimal disease burden, so timing matters
The standard approach for stage 4 pancreatic cancer typically involves chemotherapy, but clinical trials may offer access to newer targeted or immunotherapy options that could be more effective for your specific tumor.
Additional Resources
- American Cancer Society: 1-[phone removed] (can help navigate trial options)
- Your hospital's clinical trials office: Most major Boston hospitals have dedicated staff to help patients find appropriate trials
- Second opinion services: Consider getting a second opinion from a pancreatic cancer specialist, as they may know about trials not yet widely publicized
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Pancreatic Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Pancreatic Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: